{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T00:08:35Z","timestamp":1784592515793,"version":"3.55.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2019,12,7]],"date-time":"2019-12-07T00:00:00Z","timestamp":1575676800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,12,7]],"date-time":"2019-12-07T00:00:00Z","timestamp":1575676800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100014840","name":"Federal Joint Committee","doi-asserted-by":"crossref","award":["01VSF16020"],"award-info":[{"award-number":["01VSF16020"]}],"id":[{"id":"10.13039\/501100014840","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100014840","name":"Federal Joint Committee","doi-asserted-by":"crossref","award":["01VSF16020"],"award-info":[{"award-number":["01VSF16020"]}],"id":[{"id":"10.13039\/501100014840","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1007\/s00210-019-01774-4","type":"journal-article","created":{"date-parts":[[2019,12,7]],"date-time":"2019-12-07T05:00:26Z","timestamp":1575694826000},"page":"681-690","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Metamizole and the risk of drug-induced agranulocytosis and neutropenia in statutory health insurance data"],"prefix":"10.1007","volume":"393","author":[{"given":"Sebastian","family":"Klose","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ren\u00e9","family":"Pflock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inke R.","family":"K\u00f6nig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roland","family":"Linder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4510-9718","authenticated-orcid":false,"given":"Markus","family":"Schwaninger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,12,7]]},"reference":[{"key":"1774_CR1","doi-asserted-by":"publisher","first-page":"657","DOI":"10.7326\/0003-4819-146-9-200705010-00009","volume":"146","author":"F Andersohn","year":"2007","unstructured":"Andersohn F, Konzen C, Garbe E (2007) Systematic review: agranulocytosis induced by nonchemotherapy drugs. Ann Intern Med 146:657\u2013665. https:\/\/doi.org\/10.7326\/0003-4819-146-9-200705010-00009","journal-title":"Ann Intern Med"},{"key":"1774_CR2","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1111\/jcpt.12422","volume":"41","author":"S Andrade","year":"2016","unstructured":"Andrade S, Bartels DB, Lange R, Sandford L, Gurwitz J (2016) Safety of metamizole: a systematic review of the literature. J Clin Pharm Ther 41:459\u2013477. https:\/\/doi.org\/10.1111\/jcpt.12422","journal-title":"J Clin Pharm Ther"},{"key":"1774_CR3","unstructured":"Arbeitsgruppe Erhebung und Nutzung von Sekund\u00e4rdaten (AGENS) dDGfSuPDudDGfED (2012) Gute Praxis Sekund\u00e4rdatenanalyse (GPS), Leitlinien und Empfehlungen, 3. Fassung 2012"},{"key":"1774_CR4","first-page":"1758","volume":"108","author":"Arzneimittelkommission der Deutschen \u00c4rzteschaft","year":"2011","unstructured":"Arzneimittelkommission der Deutschen \u00c4rzteschaft (2011) \u201cAus der UAW-Datenbank\u201d Agranulozytose nach Metamizol \u2013 sehr selten, aber h\u00e4ufiger als gedacht. Dtsch Arztebl Int 108:1758\u20131759","journal-title":"Dtsch Arztebl Int"},{"key":"1774_CR5","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1007\/s00228-014-1781-z","volume":"71","author":"LS Blaser","year":"2015","unstructured":"Blaser LS, Tramonti A, Egger P, Haschke M, Krahenbuhl S, Ratz Bravo AE (2015) Hematological safety of metamizole: retrospective analysis of WHO and Swiss spontaneous safety reports. Eur J Clin Pharmacol 71:209\u2013217. https:\/\/doi.org\/10.1007\/s00228-014-1781-z","journal-title":"Eur J Clin Pharmacol"},{"key":"1774_CR6","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1136\/bmj.3.5875.339","volume":"3","author":"LE Bottiger","year":"1973","unstructured":"Bottiger LE, Westerholm B (1973) Drug-induced blood dyscrasias in Sweden. Br Med J 3:339\u2013343","journal-title":"Br Med J"},{"key":"1774_CR7","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/0304-3940(95)11384-9","volume":"188","author":"R Del Bo","year":"1995","unstructured":"Del Bo R, Angeretti N, Lucca E, De Simoni MG, Forloni G (1995) Reciprocal control of inflammatory cytokines, IL-1 and IL-6, and beta-amyloid production in cultures. Neurosci Lett 188:70\u201374","journal-title":"Neurosci Lett"},{"key":"1774_CR8","doi-asserted-by":"publisher","first-page":"2264","DOI":"10.1126\/science.1067568","volume":"295","author":"RB DeMattos","year":"2002","unstructured":"DeMattos RB, Bales KR, Cummins DJ, Paul SM, Holtzman DM (2002) Brain to plasma amyloid-beta efflux: a measure of brain amyloid burden in a mouse model of Alzheimer\u2019s disease. Science 295:2264\u20132267","journal-title":"Science"},{"key":"1774_CR9","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1097\/00005650-199801000-00004","volume":"36","author":"A Elixhauser","year":"1998","unstructured":"Elixhauser A, Steiner C, Harris DR, Coffey RM (1998) Comorbidity measures for use with administrative data. Med Care 36:8\u201327","journal-title":"Med Care"},{"key":"1774_CR10","unstructured":"EMA (2019) European Medicines Agency begins review of medicines containing metamizole. https:\/\/www.ema.europa.eu\/medicines\/human\/referrals\/metamizole-containing-medicinal-products. Accessed 2019 2019"},{"key":"1774_CR11","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1007\/s00103-018-2786-z","volume":"61","author":"R Foraita","year":"2018","unstructured":"Foraita R, Dijkstra L, Falkenberg F, Garling M, Linder R, Pflock R, Rizkallah MR, Schwaninger M, Wright MN, Pigeot I (2018) [Detection of drug risks after approval : methods development for the use of routine statutory health insurance data] Bundesgesundheitsblatt. Gesundheitsforschung, Gesundheitsschutz 61:1075\u20131081. https:\/\/doi.org\/10.1007\/s00103-018-2786-z","journal-title":"Gesundheitsforschung, Gesundheitsschutz"},{"key":"1774_CR12","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1177\/0269216316655746","volume":"31","author":"J Gaertner","year":"2017","unstructured":"Gaertner J et al (2017) Metamizole\/dipyrone for the relief of cancer pain: a systematic review and evidence-based recommendations for clinical practice. Palliat Med 31:26\u201334. https:\/\/doi.org\/10.1177\/0269216316655746","journal-title":"Palliat Med"},{"key":"1774_CR13","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1007\/s00103-015-2185-7","volume":"58","author":"E Garbe","year":"2015","unstructured":"Garbe E, Pigeot I (2015) [Benefits of large healthcare databases for drug risk research] Bundesgesundheitsblatt. Gesundheitsforschung, Gesundheitsschutz 58:829\u2013837. https:\/\/doi.org\/10.1007\/s00103-015-2185-7","journal-title":"Gesundheitsforschung, Gesundheitsschutz"},{"key":"1774_CR14","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/S0006-2952(02)01511-3","volume":"65","author":"JM Garcia-Martinez","year":"2003","unstructured":"Garcia-Martinez JM, Fresno Vara JA, Lastres P, Bernabeu C, Betes PO, Martin-Perez J (2003) Effect of metamizol on promyelocytic and terminally differentiated granulocytic cells. Biochem Pharmacol 65:209\u2013217","journal-title":"Biochem Pharmacol"},{"key":"1774_CR15","doi-asserted-by":"crossref","unstructured":"Haschke M, Liechti ME (2017) Metamizol: Nutzen und Risiken im Vergleich zu Paracetamol und NSAR Swiss Medical Forum - Schweizerisches Medizin-Forum:1067\u20131073","DOI":"10.4414\/smf.2017.03098"},{"key":"1774_CR16","doi-asserted-by":"publisher","first-page":"Cd011421","DOI":"10.1002\/14651858.CD011421.pub2","volume":"4","author":"L Hearn","year":"2016","unstructured":"Hearn L, Derry S, Moore RA (2016) Single dose dipyrone (metamizole) for acute postoperative pain in adults. Cochrane Database Syst Rev 4:Cd011421. https:\/\/doi.org\/10.1002\/14651858.CD011421.pub2","journal-title":"Cochrane Database Syst Rev"},{"key":"1774_CR17","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1007\/s00228-002-0465-2","volume":"58","author":"K Hedenmalm","year":"2002","unstructured":"Hedenmalm K, Spigset O (2002) Agranulocytosis and other blood dyscrasias associated with dipyrone (metamizole). Eur J Clin Pharmacol 58:265\u2013274. https:\/\/doi.org\/10.1007\/s00228-002-0465-2","journal-title":"Eur J Clin Pharmacol"},{"key":"1774_CR18","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.1007\/s00103-007-0369-5","volume":"50","author":"F Hoffmann","year":"2007","unstructured":"Hoffmann F, Pfannkuche M, Glaeske G (2007) Wie h\u00e4ufig sind Verordnungs- und Abgabedatum von Arzneimitteln in Routinedaten korrekt erfasst? Bundesgesundheitsbl Gesundheitsforsch Gesundheitsschutz 50:1418\u20131423. https:\/\/doi.org\/10.1007\/s00103-007-0369-5","journal-title":"Bundesgesundheitsbl Gesundheitsforsch Gesundheitsschutz"},{"key":"1774_CR19","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1002\/pds.3954","volume":"25","author":"F Hoffmann","year":"2016","unstructured":"Hoffmann F, Schmiemann G (2016) Pain medication in German nursing homes: a whole lot of metamizole. Pharmacoepidemiol Drug Saf 25:646\u2013651. https:\/\/doi.org\/10.1002\/pds.3954","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"1774_CR20","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1007\/s00228-014-1777-8","volume":"71","author":"M Huber","year":"2015","unstructured":"Huber M et al (2015) Metamizole-induced agranulocytosis revisited: results from the prospective Berlin case-control surveillance study. Eur J Clin Pharmacol 71:219\u2013227. https:\/\/doi.org\/10.1007\/s00228-014-1777-8","journal-title":"Eur J Clin Pharmacol"},{"key":"1774_CR21","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1001\/archinte.165.8.869","volume":"165","author":"L Ibanez","year":"2005","unstructured":"Ibanez L, Vidal X, Ballarin E, Laporte JR (2005) Population-based drug-induced agranulocytosis. Arch Intern Med 165:869\u2013874. https:\/\/doi.org\/10.1001\/archinte.165.8.869","journal-title":"Arch Intern Med"},{"key":"1774_CR22","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0122918","volume":"10","author":"T Kotter","year":"2015","unstructured":"Kotter T et al (2015) Metamizole-associated adverse events: a systematic review and meta-analysis. PLoS One 10:e0122918. https:\/\/doi.org\/10.1371\/journal.pone.0122918","journal-title":"PLoS One"},{"key":"1774_CR23","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1016\/0021-9681(87)90073-7","volume":"40","author":"MS Kramer","year":"1987","unstructured":"Kramer MS, Lane DA, Hutchinson TA (1987) Analgesic use, blood dyscrasias, and case-control pharmacoepidemiology. A critique of the International Agranulocytosis and Aplastic Anemia Study. J Chronic Dis 40:1073\u20131085","journal-title":"J Chronic Dis"},{"key":"1774_CR24","doi-asserted-by":"publisher","unstructured":"Linder R, Klose S, Verheyen F, Schwaninger M (2015) Pharmakovigilanz mit Hilfe von GKV-Abrechnungsdaten doi:https:\/\/doi.org\/10.3205\/15dkvf138","DOI":"10.3205\/15dkvf138"},{"key":"1774_CR25","doi-asserted-by":"publisher","first-page":"856","DOI":"10.3238\/arztebl.2011.0856","volume":"108","author":"S Mangiapane","year":"2011","unstructured":"Mangiapane S, Busse R (2011) Prescription prevalence and continuing medication use for secondary prevention after myocardial infarction: the reality of care revealed by claims data analysis. Deutsches Arzteblatt Int 108:856\u2013862. https:\/\/doi.org\/10.3238\/arztebl.2011.0856","journal-title":"Deutsches Arzteblatt Int"},{"key":"1774_CR26","doi-asserted-by":"publisher","first-page":"3329","DOI":"10.5504\/bbeq.2012.0089","volume":"26","author":"I Nikolova","year":"2014","unstructured":"Nikolova I, Tencheva J, Voinikov J, Petkova V, Benbasat N, Danchev N (2014) Metamizole: a review profile of a well-known \u201cforgotten\u201d drug. Part I: Pharmaceutical and Nonclinical Profile. Biotechnol Biotechnol Equip 26:3329\u20133337. https:\/\/doi.org\/10.5504\/bbeq.2012.0089","journal-title":"Biotechnol Biotechnol Equip"},{"key":"1774_CR27","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1097\/01.mlr.0000182534.19832.83","volume":"43","author":"H Quan","year":"2005","unstructured":"Quan H, Sundararajan V, Halfon P, Fong A, Burnand B, Luthi JC, Saunders LD, Beck CA, Feasby TE, Ghali WA (2005) Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care 43:1130\u20131139","journal-title":"Med Care"},{"key":"1774_CR28","doi-asserted-by":"publisher","first-page":"41","DOI":"10.2307\/2335942","volume":"70","author":"PR Rosenbaum","year":"1983","unstructured":"Rosenbaum PR, Rubin DB (1983) The Central Role of the Propensity Score in Observational Studies for Causal Effects. Biometrika 70:41\u201355. https:\/\/doi.org\/10.2307\/2335942","journal-title":"Biometrika"},{"key":"1774_CR29","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1016\/S0140-6736(03)12751-1","volume":"361","author":"P Schonhofer","year":"2003","unstructured":"Schonhofer P, Offerhaus L, Herxheimer A (2003) Dipyrone and agranulocytosis: what is the risk? Lancet 361:968\u2013969. https:\/\/doi.org\/10.1016\/S0140-6736(03)12751-1","journal-title":"Lancet"},{"key":"1774_CR30","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-662-59046-1","volume-title":"Arzneiverordnungs-Report 2019","year":"2019","unstructured":"Schwabe U, Paffrath D, Ludwig WD, Klauber J (2019) Arzneiverordnungsreport 2019. Aktuelle Daten, Kosten, Trends und Kommentare. Springer,Berlin. https:\/\/doi.org\/10.1007\/978-3-662-59046-1"},{"key":"1774_CR31","doi-asserted-by":"publisher","first-page":"17032","DOI":"10.1038\/nrdp.2017.32","volume":"3","author":"J Skokowa","year":"2017","unstructured":"Skokowa J, Dale DC, Touw IP, Zeidler C, Welte K (2017) Severe congenital neutropenias. Nat Rev Dis Prim 3:17032. https:\/\/doi.org\/10.1038\/nrdp.2017.32","journal-title":"Nat Rev Dis Prim"},{"key":"1774_CR32","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1213\/ane.0000000000002787","volume":"127","author":"SJ Staffa","year":"2018","unstructured":"Staffa SJ, Zurakowski D (2018) Five steps to successfully implement and evaluate propensity score matching in clinical research studies. Anesth Analg 127:1066\u20131073. https:\/\/doi.org\/10.1213\/ane.0000000000002787","journal-title":"Anesth Analg"},{"key":"1774_CR33","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1007\/s00228-015-1895-y","volume":"71","author":"T Stammschulte","year":"2015","unstructured":"Stammschulte T, Ludwig WD, Muhlbauer B, Bronder E, Gundert-Remy U (2015) Metamizole (dipyrone)-associated agranulocytosis. An analysis of German spontaneous reports 1990-2012. Eur J Clin Pharmacol 71:1129\u20131138. https:\/\/doi.org\/10.1007\/s00228-015-1895-y","journal-title":"Eur J Clin Pharmacol"},{"key":"1774_CR34","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1001\/jama.1986.03380130077032","volume":"256","author":"The International Agranulocytosis and Aplastic Anemia Study","year":"1986","unstructured":"The International Agranulocytosis and Aplastic Anemia Study (1986) Risks of agranulocytosis and aplastic anemia. A first report of their relation to drug use with special reference to analgesics. JAMA 256:1749\u20131757","journal-title":"JAMA"},{"key":"1774_CR35","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1001\/archinte.159.4.369","volume":"159","author":"MM van der Klauw","year":"1999","unstructured":"van der Klauw MM, Goudsmit R, Halie MR, van't Veer MB, Herings RM, Wilson JH, Stricker BH (1999) A population-based case-cohort study of drug-associated agranulocytosis. Arch Intern Med 159:369\u2013374","journal-title":"Arch Intern Med"},{"key":"1774_CR36","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1097\/MLR.0b013e31819432e5","volume":"47","author":"C van Walraven","year":"2009","unstructured":"van Walraven C, Austin PC, Jennings A, Quan H, Forster AJ (2009) A modification of the Elixhauser comorbidity measures into a point system for hospital death using administrative data. Med Care 47:626\u2013633. https:\/\/doi.org\/10.1097\/MLR.0b013e31819432e5","journal-title":"Med Care"},{"key":"1774_CR37","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1016\/j.jclinepi.2013.10.019","volume":"67","author":"M Walsh","year":"2014","unstructured":"Walsh M et al (2014) The statistical significance of randomized controlled trial results is frequently fragile: a case for a Fragility Index. J Clin Epidemiol 67:622\u2013628. https:\/\/doi.org\/10.1016\/j.jclinepi.2013.10.019","journal-title":"J Clin Epidemiol"},{"key":"1774_CR38","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1111\/bcpt.12312","volume":"116","author":"P Zapater","year":"2015","unstructured":"Zapater P et al (2015) Acute effects of dipyrone on renal function in patients with cirrhosis: a randomized controlled trial. Basic Clin Pharmacol Toxicol 116:257\u2013263. https:\/\/doi.org\/10.1111\/bcpt.12312","journal-title":"Basic Clin Pharmacol Toxicol"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-019-01774-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00210-019-01774-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-019-01774-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,6]],"date-time":"2020-12-06T00:37:56Z","timestamp":1607215076000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00210-019-01774-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,7]]},"references-count":38,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["1774"],"URL":"https:\/\/doi.org\/10.1007\/s00210-019-01774-4","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12,7]]},"assertion":[{"value":"24 October 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 November 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 December 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was conducted in accordance with the guidelines of the German Society for Epidemiology.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}